Microwave Ablation in Combination With Camrelizumab Versus Camrelizumab in Metastatic Non-small-cell Lung Cancer

NCT04102982 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

200

Enrollment

OTHER_GOV

Sponsor class

Conditions

NSCLC Stage IV

Interventions

DRUG: Camrelizumab
OTHER: Camrelizumab plus microwave ablation

Sponsor

Shandong Provincial Hospital